Cyclin D2 and cyclin D3 play opposite roles in mouse skin carcinogenesis

P Rojas1, M B Cadenas, P-C Lin

  • 1Department of Carcinogenesis, Science Park Research Division, MD Anderson Cancer Center, Smithville, TX, USA.

Oncogene
|September 20, 2006
PubMed

Insights

Cyclin D3 inhibits, while cyclin D2 promotes, skin tumor development in mice. Cyclin D3

Area of Science:

  • Cell Biology
  • Oncology
  • Molecular Biology

Background:

  • D-type cyclins regulate cell cycle progression, linking signaling pathways to G1 phase transition.
  • Previous studies examined cyclin D1, D2, and D3 overexpression in mouse skin and tumor development.

Purpose of the Study:

  • To investigate the roles of cyclin D2 and cyclin D3 in ras-dependent skin tumorigenesis.

Main Methods:

  • Overexpression of cyclin D3 and cyclin D2 in mouse skin models.
  • Analysis of tumor development, malignant progression to squamous cell carcinomas (SCC).
  • Biochemical analysis of keratinocytes and cyclin D2 kinase activity.
  • Genetic ablation and reinstatement of cyclin D2.

Main Results:

  • Cyclin D3 overexpression reduced tumor development and malignant progression to SCC.
  • Cyclin D3 overexpression led to decreased cyclin D2 levels and associated kinase activity.
  • Reinstatement of cyclin D2 reversed cyclin D3's inhibitory effects.
  • Cyclin D2 ablation reduced tumorigenesis and malignant progression.
  • Cyclin D2 overexpression increased papilloma formation and malignant progression.

Conclusions:

  • Cyclin D3 and cyclin D2 exhibit opposing roles in mouse skin tumor development.
  • Cyclin D3's tumor-suppressive activity is mediated by downregulation of cyclin D2.

Related Concept Videos

Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
Positive Regulator Molecules01:45

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...